肾透明细胞癌中血管内皮生长因子表达及微血管密度的临床病理研究
Clinicopathological significance of VEGF expression and microvascular density in renal clear cell carci-noma
目的 探讨肾透明细胞癌中血管内皮生长因子(VEGF)表达及微血管密度(MVD)的临床病理意义.方法 应用免疫组织化学方法检测VEGF蛋白表达,通过CD34抗体标记血管内皮来计算MVD值.结果 66例肾透明细胞癌VEGF蛋白表达阳性率为54.5%(36/66),其表达强弱与肿瘤分级、大小、分期等无显著相关性.MVD值为12~96.3,与肿瘤分级(P=0.005)、分期(P=0.000)相关,分级高、分期晚的透明细胞癌MVD值比分级低、分期早的低.有转移的肾透明细胞癌MVD值低,没有转移者MVD值高,差异有统计学意义(P=0.011).肿瘤体积较大时MVD50的病例(26.7%)明显少于MVD<50的病例(73.3%).VEGF和MVD值均与肾被膜累及情况无关,二者之间亦无相关性.结论 VEGF在肾透明细胞癌中的高表达,使得其可能成为治疗的靶向分子.透明细胞癌中MVD值与分级和分期呈负相关,可能有一定预后意义.
更多Objective To evaluate vascular endothelial growth factor (VEGF) expression and micro-vascular density (MVD),and their clinicopathological significance in clear cell renal carcinoma (CCRCC).Methods Immunohistochemistry method was used to examine the expression of VEGF.CD34 staining endo-thelial cells were applied to measure the MVD.Results Sixty-six cases of CCRCC were collected.VEGF ex-pressions in 36(54.5%) cases were positive.No significant relationship was detected between VEGF expres-sion and clinicopathological parameters.The MVD value was 12-96.3.The levels of MVD were significantly lower in advanced TNM staging (P=0.000),high grading (P=0.005) and metastasized tumors (P=0.011).In larger tumors,the cases of MVD 50(26.7%) were much less than those of MVD <50 (73.3%).There was no significant relationship between the expression of VEGF and MVD,and neither of them was correlated with the renal capsule infiltration.Conclusion The overexpression of VEGF in CCRCC shows that it may be the target molecule for treatment.The value of MVD is inversely correlated with the grad-ing and staging of CCRCC,indicating its significance in the prognosis assessment of CCRCC.
More- 浏览:224
- 被引:0
- 下载:8
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文